SCCM Resource Library-Basic/Translational Science

Video Transcription

Video Summary

Joe Reppold, a trauma critical care surgeon, summarizes key studies from the Journal of Critical Care Medicine over the past year. He discusses various topics, including TXA's mechanisms, ARDS biomarkers, tracheostomy timing, and red blood cell storage duration. Key insights reveal no significant timing difference in tracheostomy outcomes and no mortality difference in using fresher blood. Cardiovascular subphenotypes in ARDS indicate high mortality linked to dilated RV. He stresses the unreliability of high-dose steroids for COVID-19 and experimental procedures like Cytosorb dialysis. Reppold emphasizes personalized medicine’s potential and warns against scientific misconduct.

Asset Caption

Year in Review | Year in Review: Research Section

Meta Tag

Content Type Presentation

Membership Level Professional

Membership Level Select

Year 2024

Keywords

trauma critical care

tracheostomy timing

ARDS biomarkers

personalized medicine

scientific misconduct

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.